【SARCULATOR】版本记录-iOSApp版本更新记录-七麦数据

SARCULATOR

开发者: DIGITAL FOREST SRL

APP ID 复制

1052119173

分类

医疗

价格

免费

内购

无

0个评分

医疗(免费)

第77名

昨日下载量

最近更新

2023-11-06

最早发布

2015-11-13

版本统计

600天12小时

最新版本上线距今
0

近1年版本更新次数
2015-11-13

全球最早版本上线日期

版本记录

版本: 2.2.1

版本更新日期

2023-11-06
SARCULATOR
更新日志

Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect.

暂无更新日志数据
视频/截图
- iPhone
- iPad
应用描述

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.

Two kinds of predictions are possible:

- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

暂无应用描述数据
版本: 2.2

版本更新日期

2023-10-31
SARCULATOR
更新日志

Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect.

Aggiornamento: nuovo modello per pazienti con sarcomi primitivi del retroperitoneo che tiene in considerazione del miglioramento della prognosi osservata negli anni recenti e l’effetto del volume del centro.

暂无更新日志数据
视频/截图
- iPhone
- iPad
应用描述

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.

Two kinds of predictions are possible:

- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

暂无应用描述数据
版本: 2.1.2

版本更新日期

2022-07-28
SARCULATOR
更新日志

Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors.

暂无更新日志数据
视频/截图
- iPhone
- iPad
应用描述

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.

Two kinds of predictions are possible:

- RPS: 7-year overall survival (OS) and 7-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

暂无应用描述数据
版本: 2.1.1

版本更新日期

2022-07-27
SARCULATOR
更新日志

Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors.

暂无更新日志数据
视频/截图
- iPhone
- iPad
应用描述

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.

Two kinds of predictions are possible:

- RPS: 7-year overall survival (OS) and 7-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

暂无应用描述数据
版本: 2.1

版本更新日期

2022-07-25
SARCULATOR
更新日志

Improved interface. New dynamic nomogram to predict prognosis during follow-up in retroperitoneal sarcoma survivors.

暂无更新日志数据
视频/截图
- iPhone
- iPad
应用描述

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.

Two kinds of predictions are possible:

- RPS: 7-year overall survival (OS) and 7-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

暂无应用描述数据
版本: 2.0

版本更新日期

2019-11-13
SARCULATOR
更新日志

Support for iOS 13

暂无更新日志数据
视频/截图
- iPhone
- iPad
应用描述

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.

Two kinds of predictions are possible:

- RPS: 7-year overall survival (OS) and 7-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.

暂无应用描述数据
版本: 1.5.3

版本更新日期

2018-02-01

SARCULATOR

更新日志

New UX/UI and new features

暂无更新日志数据

应用描述

暂无应用描述数据
版本: 1.3.1

版本更新日期

2017-02-15

SARCULATOR

更新日志

bug fixes and improvements

暂无更新日志数据

应用描述

暂无应用描述数据
版本: 1.3

版本更新日期

2017-02-12

SARCULATOR

更新日志

Signin, Signout, Guest User, Save Data, Bug Fixes and improvements

暂无更新日志数据

应用描述

暂无应用描述数据
版本: 1.2

版本更新日期

2016-05-28

SARCULATOR

更新日志

bug fixes and improvements

暂无更新日志数据

应用描述

暂无应用描述数据